The Brief

Despite leadership in many research fields, Europe lags behind other world regions in the commercialisation of research results. Addressing this gap could add a significant amount to EU GDP.​

The Commission sought to explore ways in which the results generated under the €100bn flagship R&D programmes could yield further commercial results through a programme of support directed at researchers from across the EU.​

Our Solution

• BluSpecs led a consortium of partners from the UK, Poland, Spain and Lithuania. ​

  Over two years, an agile programme developed a route for researchers and early-stage technology developers to identify the commercial value of their outputs, develop strategies and network with investors and commercialisation partners.

  Activities included:​

  • The development of a maturity assessment framework​
  • Support to establish product-market fit through customer discovery and workshops involving 1,048 participants​
  • Capacity building and networking​

  Research results addressed included; biochemistry, chemistry, medicine, ICT, IoT, industrial processes, and aerospace.​

Results​